Top Clinical Trials companies in South Korea by Total Non-Current Liabilities
South Korea
# |
Name |
Total Non-Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 246.65 M
|
Dec. 31, 2023 | USD 119.86 | -2.20% |
|
South Korea |
|
| 2 |
USD 157.27 M
|
Dec. 31, 2023 | USD 54.68 | -7.62% |
|
South Korea |
|
| 3 |
USD 123.34 M
|
Dec. 31, 2023 | USD 70.28 | -5.55% |
|
South Korea |
|
| 4 |
USD 35.27 M
|
Dec. 31, 2023 | USD 10.77 | -3.15% |
|
South Korea |
|
| 5 |
USD 34.03 M
|
Dec. 31, 2023 | USD 25.27 | 1.91% |
|
South Korea |
|
| 6 |
USD 32.47 M
|
Dec. 31, 2023 | USD 1.61 | -1.19% |
|
South Korea |
|
| 7 |
USD 19.32 M
|
Dec. 31, 2023 | USD 3.04 | -3.81% |
|
South Korea |
|
| 8 |
USD 12.79 M
|
Dec. 31, 2023 | USD 1.42 | -2.25% |
|
South Korea |
|
| 9 |
USD 7.67 M
|
Dec. 31, 2023 | USD 11.62 | -0.90% |
|
South Korea |
|
| 10 |
USD 7.28 M
|
Dec. 31, 2023 | USD 64.97 | -2.50% |
|
South Korea |
|
| 11 |
USD 7.09 M
|
Dec. 31, 2023 | USD 11.83 | -21.52% |
|
South Korea |
|
| 12 |
USD 6.02 M
|
Dec. 31, 2023 | USD 240.05 | -5.25% |
|
South Korea |
|
| 13 |
USD 4.48 M
|
Dec. 31, 2023 | USD 1.23 | -3.88% |
|
South Korea |
|
| 14 |
USD 2.47 M
|
Dec. 31, 2023 | USD 11.00 | -3.03% |
|
South Korea |
|
| 15 |
USD 2.31 M
|
Dec. 31, 2023 | USD 17.88 | -1.83% |
|
South Korea |
|
| 16 |
USD 2.12 M
|
Dec. 31, 2023 | USD 1.01 | -3.22% |
|
South Korea |
|
| 17 |
USD 1.40 M
|
Dec. 31, 2023 | USD 2.33 | -4.21% |
|
South Korea |
Frequently Asked Questions
-
Which Clinical Trials company in South Korea has the highest Total Non-Current Liabilities ?
The Clinical Trials company in South Korea with the highest Total Non-Current Liabilities is Celltrion, Inc. (KSE: 068270.KS) at USD 246.65 M.
-
Which Clinical Trials company in South Korea has the lowest Total Non-Current Liabilities ?
The Clinical Trials company in South Korea with the lowest Total Non-Current Liabilities is MedPacto, Inc. (KOSDAQ: 235980.KQ) at USD 1.40 M.
-
What are the top 10 Clinical Trials companies in South Korea by Total Non-Current Liabilities ?
The top 10 Clinical Trials companies in South Korea by Total Non-Current Liabilities are Celltrion, Inc., ST Pharm Co.,Ltd., SK Biopharmaceuticals Co., Ltd., OliX Pharmaceuticals,Inc, ABL Bio Inc., CrystalGenomics, Inc., Genexine, Inc., GeneOne Life Science, Inc., Samjin Pharmaceuticals Co., Ltd. and Peptron, Inc..
-
What are the bottom 10 Clinical Trials companies in South Korea by Total Non-Current Liabilities ?
The bottom 10 Clinical Trials companies in South Korea by Total Non-Current Liabilities are MedPacto, Inc., Enzychem Lifesciences Corporation, Oscotec Inc., Boditech Med Inc., Gencurix Inc., ALTEOGEN Inc., Anterogen.Co.,Ltd., Peptron, Inc., Samjin Pharmaceuticals Co., Ltd. and GeneOne Life Science, Inc..
